The global Hyperimmune Globulin Product market was valued at 2015 million in 2024 and is projected to reach US$ 3190 million by 2031, at a CAGR of 7.0% during the forecast period.
Hyperimmune Globulin is a highly concentrated immunoglobulin containing high levels of specific antibodies used for passive immunotherapy. It is usually extracted from the plasma of recovered patients who have been infected with a specific pathogen, so these people have produced high levels of antibodies against the pathogen.
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides \"passive\" immunity to the patient against an agent. This is in contrast to vaccines that provide \"active\" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant \"passive\" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
The human plasma-based hyperimmune preparation market is driven by the increasing demand for effective treatments against specific infectious diseases and other medical conditions. Hyperimmune preparations are derived from the plasma of individuals who have recovered from a particular infection or have been vaccinated against a specific pathogen. These preparations contain high levels of antibodies targeting the specific pathogen or antigen, making them valuable for passive immunization in individuals at risk or currently affected by the same disease. The growing prevalence of infectious diseases, such as COVID-19, and the need for rapid and targeted therapeutic solutions have fueled market growth. Moreover, advancements in plasma fractionation and purification technologies have improved the production and safety of hyperimmune preparations. However, the market also faces challenges, including the complexity of large-scale plasma collection and processing, ensuring consistent antibody levels in the preparations, and maintaining a robust supply chain to meet demand during disease outbreaks or pandemics. Additionally, regulatory considerations and the need for stringent safety and quality standards are crucial challenges for manufacturers. To succeed in this market, companies must focus on research and development to expand the applications of hyperimmune preparations, collaborate with healthcare authorities and organizations to establish guidelines and protocols, and work towards enhancing plasma collection infrastructure to ensure a steady supply of human plasma-based hyperimmune preparations for critical therapeutic interventions.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hyperimmune Globulin Product manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Hyperimmune Globulin Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperimmune Globulin Product. This report contains market size and forecasts of Hyperimmune Globulin Product in global, including the following market information:
Global Hyperimmune Globulin Product market revenue, 2020-2025, 2026-2031, ($ millions)
Global Hyperimmune Globulin Product market sales, 2020-2025, 2026-2031, (K Units)
Global top five Hyperimmune Globulin Product companies in 2024 (%)
Total Market by Segment:
Global Hyperimmune Globulin Product market, by Type, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Hyperimmune Globulin Product market segment percentages, by Type, 2024 (%)
Hepatitis B Immuneglobulins
Rabies Immuneglobulins
Tetanus Toxin Immuneglobulins
Rho(D) Immune Globulin
Cytomegalovirus Immune Globulin
Varicella-Zoster Immune Globulin
Others
Global Hyperimmune Globulin Product market, by Application, 2020-2025, 2026-2031 ($ Millions) & (K Units)
Global Hyperimmune Globulin Product market segment percentages, by Application, 2024 (%)
Government Institution
Private Sector
Others
Global Hyperimmune Globulin Product market, by region and country, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Hyperimmune Globulin Product market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hyperimmune Globulin Product revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Hyperimmune Globulin Product revenues share in global market, 2024 (%)
Key companies Hyperimmune Globulin Product sales in global market, 2020-2025 (estimated), (K Units)
Key companies Hyperimmune Globulin Product sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
CSL Behring
Grifols
Biotest
Kedrion
Emergent
Kamada
CNBG
Hualan Bio
Shanghai RAAS
CBPO
Sichuan Yuanda Shuyang
ADMA Biologics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hyperimmune Globulin Product, market overview.
Chapter 2: Global Hyperimmune Globulin Product market size in revenue and volume.
Chapter 3: Detailed analysis of Hyperimmune Globulin Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hyperimmune Globulin Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hyperimmune Globulin Product capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Hyperimmune Globulin Product Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Hyperimmune Globulin Product Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hyperimmune Globulin Product Overall Market Size
2.1 Global Hyperimmune Globulin Product Market Size: 2024 VS 2031
2.2 Global Hyperimmune Globulin Product Market Size, Prospects & Forecasts: 2020-2031
2.3 Global Hyperimmune Globulin Product Sales: 2020-2031
3 Company Landscape
3.1 Top Hyperimmune Globulin Product Players in Global Market
3.2 Top Global Hyperimmune Globulin Product Companies Ranked by Revenue
3.3 Global Hyperimmune Globulin Product Revenue by Companies
3.4 Global Hyperimmune Globulin Product Sales by Companies
3.5 Global Hyperimmune Globulin Product Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Hyperimmune Globulin Product Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Hyperimmune Globulin Product Product Type
3.8 Tier 1, Tier 2, and Tier 3 Hyperimmune Globulin Product Players in Global Market
3.8.1 List of Global Tier 1 Hyperimmune Globulin Product Companies
3.8.2 List of Global Tier 2 and Tier 3 Hyperimmune Globulin Product Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Hyperimmune Globulin Product Market Size Markets, 2024 & 2031
4.1.2 Hepatitis B Immuneglobulins
4.1.3 Rabies Immuneglobulins
4.1.4 Tetanus Toxin Immuneglobulins
4.1.5 Rho(D) Immune Globulin
4.1.6 Cytomegalovirus Immune Globulin
4.1.7 Varicella-Zoster Immune Globulin
4.1.8 Others
4.2 Segment by Type - Global Hyperimmune Globulin Product Revenue & Forecasts
4.2.1 Segment by Type - Global Hyperimmune Globulin Product Revenue, 2020-2025
4.2.2 Segment by Type - Global Hyperimmune Globulin Product Revenue, 2026-2031
4.2.3 Segment by Type - Global Hyperimmune Globulin Product Revenue Market Share, 2020-2031
4.3 Segment by Type - Global Hyperimmune Globulin Product Sales & Forecasts
4.3.1 Segment by Type - Global Hyperimmune Globulin Product Sales, 2020-2025
4.3.2 Segment by Type - Global Hyperimmune Globulin Product Sales, 2026-2031
4.3.3 Segment by Type - Global Hyperimmune Globulin Product Sales Market Share, 2020-2031
4.4 Segment by Type - Global Hyperimmune Globulin Product Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Hyperimmune Globulin Product Market Size, 2024 & 2031
5.1.2 Government Institution
5.1.3 Private Sector
5.1.4 Others
5.2 Segment by Application - Global Hyperimmune Globulin Product Revenue & Forecasts
5.2.1 Segment by Application - Global Hyperimmune Globulin Product Revenue, 2020-2025
5.2.2 Segment by Application - Global Hyperimmune Globulin Product Revenue, 2026-2031
5.2.3 Segment by Application - Global Hyperimmune Globulin Product Revenue Market Share, 2020-2031
5.3 Segment by Application - Global Hyperimmune Globulin Product Sales & Forecasts
5.3.1 Segment by Application - Global Hyperimmune Globulin Product Sales, 2020-2025
5.3.2 Segment by Application - Global Hyperimmune Globulin Product Sales, 2026-2031
5.3.3 Segment by Application - Global Hyperimmune Globulin Product Sales Market Share, 2020-2031
5.4 Segment by Application - Global Hyperimmune Globulin Product Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region - Global Hyperimmune Globulin Product Market Size, 2024 & 2031
6.2 By Region - Global Hyperimmune Globulin Product Revenue & Forecasts
6.2.1 By Region - Global Hyperimmune Globulin Product Revenue, 2020-2025
6.2.2 By Region - Global Hyperimmune Globulin Product Revenue, 2026-2031
6.2.3 By Region - Global Hyperimmune Globulin Product Revenue Market Share, 2020-2031
6.3 By Region - Global Hyperimmune Globulin Product Sales & Forecasts
6.3.1 By Region - Global Hyperimmune Globulin Product Sales, 2020-2025
6.3.2 By Region - Global Hyperimmune Globulin Product Sales, 2026-2031
6.3.3 By Region - Global Hyperimmune Globulin Product Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country - North America Hyperimmune Globulin Product Revenue, 2020-2031
6.4.2 By Country - North America Hyperimmune Globulin Product Sales, 2020-2031
6.4.3 United States Hyperimmune Globulin Product Market Size, 2020-2031
6.4.4 Canada Hyperimmune Globulin Product Market Size, 2020-2031
6.4.5 Mexico Hyperimmune Globulin Product Market Size, 2020-2031
6.5 Europe
6.5.1 By Country - Europe Hyperimmune Globulin Product Revenue, 2020-2031
6.5.2 By Country - Europe Hyperimmune Globulin Product Sales, 2020-2031
6.5.3 Germany Hyperimmune Globulin Product Market Size, 2020-2031
6.5.4 France Hyperimmune Globulin Product Market Size, 2020-2031
6.5.5 U.K. Hyperimmune Globulin Product Market Size, 2020-2031
6.5.6 Italy Hyperimmune Globulin Product Market Size, 2020-2031
6.5.7 Russia Hyperimmune Globulin Product Market Size, 2020-2031
6.5.8 Nordic Countries Hyperimmune Globulin Product Market Size, 2020-2031
6.5.9 Benelux Hyperimmune Globulin Product Market Size, 2020-2031
6.6 Asia
6.6.1 By Region - Asia Hyperimmune Globulin Product Revenue, 2020-2031
6.6.2 By Region - Asia Hyperimmune Globulin Product Sales, 2020-2031
6.6.3 China Hyperimmune Globulin Product Market Size, 2020-2031
6.6.4 Japan Hyperimmune Globulin Product Market Size, 2020-2031
6.6.5 South Korea Hyperimmune Globulin Product Market Size, 2020-2031
6.6.6 Southeast Asia Hyperimmune Globulin Product Market Size, 2020-2031
6.6.7 India Hyperimmune Globulin Product Market Size, 2020-2031
6.7 South America
6.7.1 By Country - South America Hyperimmune Globulin Product Revenue, 2020-2031
6.7.2 By Country - South America Hyperimmune Globulin Product Sales, 2020-2031
6.7.3 Brazil Hyperimmune Globulin Product Market Size, 2020-2031
6.7.4 Argentina Hyperimmune Globulin Product Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hyperimmune Globulin Product Revenue, 2020-2031
6.8.2 By Country - Middle East & Africa Hyperimmune Globulin Product Sales, 2020-2031
6.8.3 Turkey Hyperimmune Globulin Product Market Size, 2020-2031
6.8.4 Israel Hyperimmune Globulin Product Market Size, 2020-2031
6.8.5 Saudi Arabia Hyperimmune Globulin Product Market Size, 2020-2031
6.8.6 UAE Hyperimmune Globulin Product Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 CSL Behring
7.1.1 CSL Behring Company Summary
7.1.2 CSL Behring Business Overview
7.1.3 CSL Behring Hyperimmune Globulin Product Major Product Offerings
7.1.4 CSL Behring Hyperimmune Globulin Product Sales and Revenue in Global (2020-2025)
7.1.5 CSL Behring Key News & Latest Developments
7.2 Grifols
7.2.1 Grifols Company Summary
7.2.2 Grifols Business Overview
7.2.3 Grifols Hyperimmune Globulin Product Major Product Offerings
7.2.4 Grifols Hyperimmune Globulin Product Sales and Revenue in Global (2020-2025)
7.2.5 Grifols Key News & Latest Developments
7.3 Biotest
7.3.1 Biotest Company Summary
7.3.2 Biotest Business Overview
7.3.3 Biotest Hyperimmune Globulin Product Major Product Offerings
7.3.4 Biotest Hyperimmune Globulin Product Sales and Revenue in Global (2020-2025)
7.3.5 Biotest Key News & Latest Developments
7.4 Kedrion
7.4.1 Kedrion Company Summary
7.4.2 Kedrion Business Overview
7.4.3 Kedrion Hyperimmune Globulin Product Major Product Offerings
7.4.4 Kedrion Hyperimmune Globulin Product Sales and Revenue in Global (2020-2025)
7.4.5 Kedrion Key News & Latest Developments
7.5 Emergent
7.5.1 Emergent Company Summary
7.5.2 Emergent Business Overview
7.5.3 Emergent Hyperimmune Globulin Product Major Product Offerings
7.5.4 Emergent Hyperimmune Globulin Product Sales and Revenue in Global (2020-2025)
7.5.5 Emergent Key News & Latest Developments
7.6 Kamada
7.6.1 Kamada Company Summary
7.6.2 Kamada Business Overview
7.6.3 Kamada Hyperimmune Globulin Product Major Product Offerings
7.6.4 Kamada Hyperimmune Globulin Product Sales and Revenue in Global (2020-2025)
7.6.5 Kamada Key News & Latest Developments
7.7 CNBG
7.7.1 CNBG Company Summary
7.7.2 CNBG Business Overview
7.7.3 CNBG Hyperimmune Globulin Product Major Product Offerings
7.7.4 CNBG Hyperimmune Globulin Product Sales and Revenue in Global (2020-2025)
7.7.5 CNBG Key News & Latest Developments
7.8 Hualan Bio
7.8.1 Hualan Bio Company Summary
7.8.2 Hualan Bio Business Overview
7.8.3 Hualan Bio Hyperimmune Globulin Product Major Product Offerings
7.8.4 Hualan Bio Hyperimmune Globulin Product Sales and Revenue in Global (2020-2025)
7.8.5 Hualan Bio Key News & Latest Developments
7.9 Shanghai RAAS
7.9.1 Shanghai RAAS Company Summary
7.9.2 Shanghai RAAS Business Overview
7.9.3 Shanghai RAAS Hyperimmune Globulin Product Major Product Offerings
7.9.4 Shanghai RAAS Hyperimmune Globulin Product Sales and Revenue in Global (2020-2025)
7.9.5 Shanghai RAAS Key News & Latest Developments
7.10 CBPO
7.10.1 CBPO Company Summary
7.10.2 CBPO Business Overview
7.10.3 CBPO Hyperimmune Globulin Product Major Product Offerings
7.10.4 CBPO Hyperimmune Globulin Product Sales and Revenue in Global (2020-2025)
7.10.5 CBPO Key News & Latest Developments
7.11 Sichuan Yuanda Shuyang
7.11.1 Sichuan Yuanda Shuyang Company Summary
7.11.2 Sichuan Yuanda Shuyang Business Overview
7.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulin Product Major Product Offerings
7.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulin Product Sales and Revenue in Global (2020-2025)
7.11.5 Sichuan Yuanda Shuyang Key News & Latest Developments
7.12 ADMA Biologics
7.12.1 ADMA Biologics Company Summary
7.12.2 ADMA Biologics Business Overview
7.12.3 ADMA Biologics Hyperimmune Globulin Product Major Product Offerings
7.12.4 ADMA Biologics Hyperimmune Globulin Product Sales and Revenue in Global (2020-2025)
7.12.5 ADMA Biologics Key News & Latest Developments
8 Global Hyperimmune Globulin Product Production Capacity, Analysis
8.1 Global Hyperimmune Globulin Product Production Capacity, 2020-2031
8.2 Hyperimmune Globulin Product Production Capacity of Key Manufacturers in Global Market
8.3 Global Hyperimmune Globulin Product Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hyperimmune Globulin Product Supply Chain Analysis
10.1 Hyperimmune Globulin Product Industry Value Chain
10.2 Hyperimmune Globulin Product Upstream Market
10.3 Hyperimmune Globulin Product Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hyperimmune Globulin Product Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Hyperimmune Globulin Product in Global Market
Table 2. Top Hyperimmune Globulin Product Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Hyperimmune Globulin Product Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Hyperimmune Globulin Product Revenue Share by Companies, 2020-2025
Table 5. Global Hyperimmune Globulin Product Sales by Companies, (K Units), 2020-2025
Table 6. Global Hyperimmune Globulin Product Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Hyperimmune Globulin Product Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Hyperimmune Globulin Product Product Type
Table 9. List of Global Tier 1 Hyperimmune Globulin Product Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hyperimmune Globulin Product Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global Hyperimmune Globulin Product Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type - Global Hyperimmune Globulin Product Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Hyperimmune Globulin Product Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type - Global Hyperimmune Globulin Product Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Hyperimmune Globulin Product Sales (K Units), 2026-2031
Table 16. Segment by Application – Global Hyperimmune Globulin Product Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application - Global Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Hyperimmune Globulin Product Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application - Global Hyperimmune Globulin Product Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Hyperimmune Globulin Product Sales, (K Units), 2026-2031
Table 21. By Region – Global Hyperimmune Globulin Product Revenue, (US$, Mn), 2025-2031
Table 22. By Region - Global Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Hyperimmune Globulin Product Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Global Hyperimmune Globulin Product Sales, (K Units), 2020-2025
Table 25. By Region - Global Hyperimmune Globulin Product Sales, (K Units), 2026-2031
Table 26. By Country - North America Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Hyperimmune Globulin Product Revenue, (US$, Mn), 2026-2031
Table 28. By Country - North America Hyperimmune Globulin Product Sales, (K Units), 2020-2025
Table 29. By Country - North America Hyperimmune Globulin Product Sales, (K Units), 2026-2031
Table 30. By Country - Europe Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Hyperimmune Globulin Product Revenue, (US$, Mn), 2026-2031
Table 32. By Country - Europe Hyperimmune Globulin Product Sales, (K Units), 2020-2025
Table 33. By Country - Europe Hyperimmune Globulin Product Sales, (K Units), 2026-2031
Table 34. By Region - Asia Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Hyperimmune Globulin Product Revenue, (US$, Mn), 2026-2031
Table 36. By Region - Asia Hyperimmune Globulin Product Sales, (K Units), 2020-2025
Table 37. By Region - Asia Hyperimmune Globulin Product Sales, (K Units), 2026-2031
Table 38. By Country - South America Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Hyperimmune Globulin Product Revenue, (US$, Mn), 2026-2031
Table 40. By Country - South America Hyperimmune Globulin Product Sales, (K Units), 2020-2025
Table 41. By Country - South America Hyperimmune Globulin Product Sales, (K Units), 2026-2031
Table 42. By Country - Middle East & Africa Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Hyperimmune Globulin Product Revenue, (US$, Mn), 2026-2031
Table 44. By Country - Middle East & Africa Hyperimmune Globulin Product Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Hyperimmune Globulin Product Sales, (K Units), 2026-2031
Table 46. CSL Behring Company Summary
Table 47. CSL Behring Hyperimmune Globulin Product Product Offerings
Table 48. CSL Behring Hyperimmune Globulin Product Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. CSL Behring Key News & Latest Developments
Table 50. Grifols Company Summary
Table 51. Grifols Hyperimmune Globulin Product Product Offerings
Table 52. Grifols Hyperimmune Globulin Product Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Grifols Key News & Latest Developments
Table 54. Biotest Company Summary
Table 55. Biotest Hyperimmune Globulin Product Product Offerings
Table 56. Biotest Hyperimmune Globulin Product Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Biotest Key News & Latest Developments
Table 58. Kedrion Company Summary
Table 59. Kedrion Hyperimmune Globulin Product Product Offerings
Table 60. Kedrion Hyperimmune Globulin Product Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Kedrion Key News & Latest Developments
Table 62. Emergent Company Summary
Table 63. Emergent Hyperimmune Globulin Product Product Offerings
Table 64. Emergent Hyperimmune Globulin Product Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Emergent Key News & Latest Developments
Table 66. Kamada Company Summary
Table 67. Kamada Hyperimmune Globulin Product Product Offerings
Table 68. Kamada Hyperimmune Globulin Product Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Kamada Key News & Latest Developments
Table 70. CNBG Company Summary
Table 71. CNBG Hyperimmune Globulin Product Product Offerings
Table 72. CNBG Hyperimmune Globulin Product Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. CNBG Key News & Latest Developments
Table 74. Hualan Bio Company Summary
Table 75. Hualan Bio Hyperimmune Globulin Product Product Offerings
Table 76. Hualan Bio Hyperimmune Globulin Product Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Hualan Bio Key News & Latest Developments
Table 78. Shanghai RAAS Company Summary
Table 79. Shanghai RAAS Hyperimmune Globulin Product Product Offerings
Table 80. Shanghai RAAS Hyperimmune Globulin Product Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. Shanghai RAAS Key News & Latest Developments
Table 82. CBPO Company Summary
Table 83. CBPO Hyperimmune Globulin Product Product Offerings
Table 84. CBPO Hyperimmune Globulin Product Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. CBPO Key News & Latest Developments
Table 86. Sichuan Yuanda Shuyang Company Summary
Table 87. Sichuan Yuanda Shuyang Hyperimmune Globulin Product Product Offerings
Table 88. Sichuan Yuanda Shuyang Hyperimmune Globulin Product Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. Sichuan Yuanda Shuyang Key News & Latest Developments
Table 90. ADMA Biologics Company Summary
Table 91. ADMA Biologics Hyperimmune Globulin Product Product Offerings
Table 92. ADMA Biologics Hyperimmune Globulin Product Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. ADMA Biologics Key News & Latest Developments
Table 94. Hyperimmune Globulin Product Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 95. Global Hyperimmune Globulin Product Capacity Market Share of Key Manufacturers, 2023-2025
Table 96. Global Hyperimmune Globulin Product Production by Region, 2020-2025 (K Units)
Table 97. Global Hyperimmune Globulin Product Production by Region, 2026-2031 (K Units)
Table 98. Hyperimmune Globulin Product Market Opportunities & Trends in Global Market
Table 99. Hyperimmune Globulin Product Market Drivers in Global Market
Table 100. Hyperimmune Globulin Product Market Restraints in Global Market
Table 101. Hyperimmune Globulin Product Raw Materials
Table 102. Hyperimmune Globulin Product Raw Materials Suppliers in Global Market
Table 103. Typical Hyperimmune Globulin Product Downstream
Table 104. Hyperimmune Globulin Product Downstream Clients in Global Market
Table 105. Hyperimmune Globulin Product Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hyperimmune Globulin Product Product Picture
Figure 2. Hyperimmune Globulin Product Segment by Type in 2024
Figure 3. Hyperimmune Globulin Product Segment by Application in 2024
Figure 4. Global Hyperimmune Globulin Product Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Hyperimmune Globulin Product Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Hyperimmune Globulin Product Revenue: 2020-2031 (US$, Mn)
Figure 8. Hyperimmune Globulin Product Sales in Global Market: 2020-2031 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Hyperimmune Globulin Product Revenue in 2024
Figure 10. Segment by Type – Global Hyperimmune Globulin Product Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type - Global Hyperimmune Globulin Product Revenue Market Share, 2020-2031
Figure 12. Segment by Type - Global Hyperimmune Globulin Product Sales Market Share, 2020-2031
Figure 13. Segment by Type - Global Hyperimmune Globulin Product Price (US$/Unit), 2020-2031
Figure 14. Segment by Application – Global Hyperimmune Globulin Product Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application - Global Hyperimmune Globulin Product Revenue Market Share, 2020-2031
Figure 16. Segment by Application - Global Hyperimmune Globulin Product Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global Hyperimmune Globulin Product Price (US$/Unit), 2020-2031
Figure 18. By Region – Global Hyperimmune Globulin Product Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region - Global Hyperimmune Globulin Product Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region - Global Hyperimmune Globulin Product Revenue Market Share, 2020-2031
Figure 21. By Region - Global Hyperimmune Globulin Product Sales Market Share, 2020-2031
Figure 22. By Country - North America Hyperimmune Globulin Product Revenue Market Share, 2020-2031
Figure 23. By Country - North America Hyperimmune Globulin Product Sales Market Share, 2020-2031
Figure 24. United States Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 25. Canada Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 27. By Country - Europe Hyperimmune Globulin Product Revenue Market Share, 2020-2031
Figure 28. By Country - Europe Hyperimmune Globulin Product Sales Market Share, 2020-2031
Figure 29. Germany Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 30. France Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 32. Italy Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 33. Russia Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 36. By Region - Asia Hyperimmune Globulin Product Revenue Market Share, 2020-2031
Figure 37. By Region - Asia Hyperimmune Globulin Product Sales Market Share, 2020-2031
Figure 38. China Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 39. Japan Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 42. India Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 43. By Country - South America Hyperimmune Globulin Product Revenue Market Share, 2020-2031
Figure 44. By Country - South America Hyperimmune Globulin Product Sales, Market Share, 2020-2031
Figure 45. Brazil Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 47. By Country - Middle East & Africa Hyperimmune Globulin Product Revenue, Market Share, 2020-2031
Figure 48. By Country - Middle East & Africa Hyperimmune Globulin Product Sales, Market Share, 2020-2031
Figure 49. Turkey Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 50. Israel Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 52. UAE Hyperimmune Globulin Product Revenue, (US$, Mn), 2020-2031
Figure 53. Global Hyperimmune Globulin Product Production Capacity (K Units), 2020-2031
Figure 54. The Percentage of Production Hyperimmune Globulin Product by Region, 2024 VS 2031
Figure 55. Hyperimmune Globulin Product Industry Value Chain
Figure 56. Marketing Channels
